ACS
ADAP

Archford Capital Strategies’s Adaptimmune Therapeutics ADAP Stock Holding History

Archford Capital Strategies’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,000
Closed -$4K – 216
2019
Q2 		$4K Buy
+1,000
New +$4K ﹤0.01% 473